Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Hyperleukocytosis and outcomes in pediatric B-cell acute lymphoblastic leukemia: A report from the REDIAL Consortium.
Journal: medRxiv : the preprint server for health sciences
Published: June 29, 2026
Hyperleukocytosis and outcomes in pediatric B-cell acute lymphoblastic leukemia: A report from the REDIAL Consortium.
Journal: medRxiv : the preprint server for health sciences
Published: June 29, 2026
A Framework for Prioritizing Novel Agents in Malignant Peripheral Nerve Sheath Tumor Trials: A report from the Neurofibromatosis Clinical Trials Consortium.
Journal: Neuro-oncology
Published: May 13, 2026
Cardiac Monitoring for Patients Undergoing Treatment With MEK Inhibitor Monotherapy.
Journal: Current oncology reports
Published: May 05, 2026
Admixture Mapping Reveals Candidate Regions for Methotrexate Neurotoxicity Susceptibility: A Reducing Disparities in Acute Leukemia Consortium Report.
Journal: Pediatric blood & cancer
Published: March 25, 2026
MEK inhibitor Mirdametinib promotes fracture healing in osteofibrous dysplasia RASopathy.
Journal: The Journal of clinical investigation
Published: February 26, 2026
Interplay between Genetic Ancestry, Self-reported Race and Ethnicity, and Clinical Factors in Pediatric Acute Lymphoblastic Leukemia: A REDIAL Consortium Report.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: October 02, 2025
MEK inhibitor mirdametinib promotes fracture healing in osteofibrous dysplasia RASopathy.
Journal: The Journal of clinical investigation
Published: August 12, 2025
Genome-wide association study of childhood B-cell acute lymphoblastic leukemia reveals novel African ancestry-specific susceptibility loci.
Journal: Nature communications
Published: May 09, 2025
Last Updated: 09/26/2026